Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

Personal View

HepatologyCirrhosis and portal hypertension

Variceal hemorrhage

Click a heading in the right-hand column to see the selected articles in that subject area

See any comments for this Personal View

T Roesch What to do after endoscopic histoacryl injection for acute fundic variceal bleeding?
T Roesch, 22 May 2006

A comment on: Endoscopic histoacryl obilteration vs. propanolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Evrad S, Dumonceau JM, Delhaye M, Golstein P, Deviere J, LeMoine O Endoscopy 2003; 35: 730-736.

Histoacryl injection was introduced by Nib Soehendra to solve a difficult and hitherto unsatisfatorily solved clinical situation (Endoscopy 1986; 18: 25-26). The patient with acute bleeding from fundic varices, which can be a life-threatening situation, is quite difficult to manage, due to poor visibilty and limited possibilities of endoscopic therapy

This contrasts with the treatment for esophageal varices, where sclerotherapy and banding are firmly incorportated into the therapeutic armamentarium.

Successful hemostasis can be achieved in 80-90% of cases of fundic varices (Endoscopy 2002; 34: 926-32). The crucial question is, whether and how to continue, since the rebleeding rate from other remaining fundic varices may be high (although this has never been syste-matically studied in a large collective).

The Brussels group of Evrad et al. addresses this question in a randomized trail of 41 patients. They, however, did not include a control group without any further therapy, and, in fact, beta-blockers may represent the current standard in these cases.

Continuing Histoacryl obliteration in a mean of 5 further sessions after initial hemostasis (achieved in 97% of cases) was compared to propoanolol administration (80 mg/day). During a follow-up of 32 months (Histoacryl) and 23 months (propanolol), the number of early and late rebleedings was not significantly different, nor was the death rate in any way difference. More complications were encountered in the Histoacryl group (see Table 1).

 
Table 1. Outcome data of Histoacryl obliteration versus propanolol group
 
 

Histoacryl
(n = 21)

Propanolol
(n = 20)
 

Early rebleeding
5
3
 
Early mortality
3
6
 
Late rebleeding
11
5
 
Late mortality
9
9
 
Complications
10
2
p > 0.02

Early - within 6 weeks.

We can therefore conclude that it is probably not worthwhile to continue Histoacryl injection after initial hemostasis for any remaining varices, but to put patients on propanolol.

Join the debate! Click here to post your comments about this Personal View Speech.

Although this study is small, it comes from an experienced endoscopy center (so that nobody can accuse them of lacking experience with Histoacryl) and the trend in rebleeding and early mortality rates was numerically in favour of propanolol. A larger study may have given stronger support to the use of beta-blockers. Randomized studies in endoscopy have to be supported and Ervad et al. are to be congratulated for clarifying this clinically important question.

Go to top of page

YourComments

Go to top of page Email this page Email this page to a colleague

 29 July 2014

Advanced search
Close folder Gastroenterology
Mouth
Esophagus
Stomach & duodenum
Helicobacter pylori
Small intestine
Colo-rectum and anus
Pancreas
Inflammatory bowel disease
Functional bowel disorders
Nutrition
Symptoms/signs of gastrointestinal disease
Basic science
Close folder Hepatology
Biliary tract
Viral hepatitis
Liver diseases
  Cirrhosis and portal hypertension
Liver transplantation
Liver & other diseases
Pediatric hepatology
Basic science
Close folder Endoscopy
Upper endoscopy
ERCP
Colonoscopy
Endoscopic ultrasound
Technology
Practice issues

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us